Fraunhofer Institut für Zuverlässigkeit und Mikrointegration IZM

Integration of biosensors for point-of-care applications

The number of people infected with the novel SARS-CoV-2 virus is rapidly increasing worldwide. Affected countries are adopting new measures almost daily to contain the spread, while medical laboratories are working not only on a vaccine but also on new test methods. For the time being, Bosch wants to launch a new rapid test in Germany that shows a result at the test site in under 2.5 hours instead of the previous 2 days. This technical solution is based on a PoC analysis platform, which was developed together with Fraunhofer IZM in the EU project CAJAL4EU. The main objective of the project was to develop miniaturized biosensor technology platforms that enable fast, robust, user-friendly and cost-effective multi-parameter in vitro test applications.

This project was supported by the EU (funding code: FP7-ENIAC-120215) and BMBF (funding code: 13N10925) within the framework of FP7.